First, the expression level of NPC1 in patients with metabolic syndrome and CAD seems to be higher than that of healthy subjects and a similar trend can be seen from the comparison between the two groups of ruptured plaque and stable plaque (Figure 2A), indicating up-regulation of the NPC1 may lead to an increased risk of cardiac disease. The gene discussed is NPC1; the disease is metabolic syndrome.